Search Results

Monoclonal Antibodies for HIV—Lessons Learned from COVID-19 - Daniel Kuritzkes

Monoclonal Antibodies for HIV—Lessons Learned from COVID-19 - Daniel Kuritzkes

Small Molecules and mAbs as Antiviral Therapy for COVID-19 | Daniel Kuritzkes

Small Molecules and mAbs as Antiviral Therapy for COVID-19 | Daniel Kuritzkes

Current & Evolving Therapeutic Options for Highly Treatment Experienced Patients - Daniel Kuritzkes

Current & Evolving Therapeutic Options for Highly Treatment Experienced Patients - Daniel Kuritzkes

Monoclonal Antibodies for Treatment in HIV - Marina Caskey, MD

Monoclonal Antibodies for Treatment in HIV - Marina Caskey, MD

Monoclonal Antibodies for Prevention of HIV, COVID, and Ebola - Myron S. Cohen, MD, BS

Monoclonal Antibodies for Prevention of HIV, COVID, and Ebola - Myron S. Cohen, MD, BS

Update on COVID-19 Therapeutics - Daniel Kuritzkes, MD

Update on COVID-19 Therapeutics - Daniel Kuritzkes, MD

Update on COVID-19 Therapeutics - Daniel Kuritzkes, MD

Update on COVID-19 Therapeutics - Daniel Kuritzkes, MD

Treatment Options for the Complex Patient: What are the Options? - Daniel Kuritzkes, MD

Treatment Options for the Complex Patient: What are the Options? - Daniel Kuritzkes, MD

Monoclonal Antibodies for HIV Prevention - Carlos del Rio

Monoclonal Antibodies for HIV Prevention - Carlos del Rio

Update on Therapeutics for COVID-19 - Daniel R. Kuritzkes, MD

Update on Therapeutics for COVID-19 - Daniel R. Kuritzkes, MD

Daniel Kuritzkes | Update on Clinical Trials of Drugs for Patients with Limited Treatment Options

Daniel Kuritzkes | Update on Clinical Trials of Drugs for Patients with Limited Treatment Options

Therapeutics for COVID-19 - Daniel R. Kuritzkes

Therapeutics for COVID-19 - Daniel R. Kuritzkes